Clinical trials - Press Releases

Date	Title	Company
11-Nov-2019	Roxadustat Phase III programme pooled analyses showed positive efficacy and no increased cardiovascular risk in patients with anaemia from chronic kidney disease	AstraZeneca
11-Nov-2019	World’s First Cyclic IMS Mass Spectrometer Installed at Aston University	Aston University
11-Nov-2019	BioNTech to Report Third Quarter 2019 Financial Results and Operational Progress on November 14, 2019	BioNTech SE
11-Nov-2019	Mallinckrodt Announces UVADEX® (Methoxsalen) Approved in Australia for use with the THERAKOS® CELLEX® Photopheresis System for Treatment of Chronic Graft Versus Host Disease (cGvHD) and Skin Manifestations of Cutaneous T-Cell Lymphoma (CTCL) in Adults	Mallinckrodt
08-Nov-2019	BioNTech to Report Third Quarter 2019 Financial Results and Operational Progress on November 14, 2019	BioNTech SE
08-Nov-2019	Mallinckrodt Announces UVADEX® (Methoxsalen) Approved in Australia for use with the THERAKOS® CELLEX® Photopheresis System for Treatment of Chronic Graft Versus Host Disease (cGvHD) and Skin Manifestations of Cutaneous T-Cell Lymphoma (CTCL) in	Mallinckrodt plc
08-Nov-2019	Pooled Analyses of Bempedoic Acid Phase 3 LDL-C Lowering Clinical Trial Programme to be Presented at the American Heart Association 2019 Scientific Sessions	Daiichi Sankyo
08-Nov-2019	Bavarian Nordic Announces Submission of European Marketing Authorisation Applications for Investigational Ebola Vaccine Regimen	Bavarian Nordic A/S
08-Nov-2019	Bioeq announces Coherus as marketing and distribution partner for its biosimilar to Lucentis® (ranibizumab) in the U.S.	Bioeq
08-Nov-2019	Immutep presents positive interim data from phase II TACTI-002 trial at SITC	Immutep
08-Nov-2019	OBN Awards 2019 – Winners Recognised at Industry Leading Event	OBN
07-Nov-2019	TrialScope Announces Winners of 2nd Annual Clārus Awards at Clinical Trial Transparency Conference	TrialScope
07-Nov-2019	Signant Health Host 8th Annual eCOA Forum To Convene Clinical Operations and Outcomes Research Leaders Guiding the Future of Patient-Centric Technology	Signant Health
07-Nov-2019	Combatting Counterfeiters	Neo PR Limited
07-Nov-2019	TrialAssure Launches First-in-Class Document Anonymization Tool Using Machine Learning and Artificial Intelligence to Protect Patient Data	TrialAssure
07-Nov-2019	Signant Health Proud to Sponsor the Philadelphia Walk to End Alzheimer’s in Nationwide Effort to Build Awareness, Raise Funds and Advance Research Towards a Cure.	Signant Health
07-Nov-2019	Artios Pharma, MD Anderson and ShangPharma announce in-licensing agreement for DNA damage response inhibitor	Artios Pharma Limited
07-Nov-2019	Urania Therapeutics closes a €3.5M initial seed round	Advent France Biotechnology
07-Nov-2019	Freeline to present data on AAV-based gene therapies for Gaucher Disease and Haemophilia A at the 61st ASH Annual Meeting	Freeline
07-Nov-2019	Recent Advances in Bavarian Nordic’s Cancer Immunotherapy Platform Published in Nature Communications	Bavarian Nordic